Virtus Fund Advisers’s Core Laboratories CLB Stock Holding History

Virtus Fund Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$45.4M	Buy	414,825 +12,650	+3%	+$1.26M	0.45%	94
2017 Q3	$39.7M	Buy	402,175 +46,950	+13%	+$4.55M	0.4%	112
2017 Q2	$36.5M	Sell	355,225 -700	-0.2%	-$75.5K	0.36%	131
2017 Q1	$41.1M	Buy	+355,925	New	+$41.4M	0.39%	119

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Virtus Fund Advisers's CLB Position: Q4 2017 in Review

Virtus Fund Advisers increased its Core Laboratories (CLB) stake by 3.1% in Q4 2017, buying an estimated $1.26M and bringing the position to 414,825 shares worth $45.4M. The position accounts for 0.45% of the portfolio, ranked #94.

Virtus Fund Advisers first reported a position in CLB in Q1 2017 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Virtus Fund Advisers held 414,825 shares of Core Laboratories worth $45.4M as of Q4 2017.
Virtus Fund Advisers bought 12,650 Core Laboratories shares in Q4 2017, an estimated $1.26M.
Core Laboratories made up 0.45% of Virtus Fund Advisers's portfolio in Q4 2017, its #94 holding.
Virtus Fund Advisers first reported a position in Core Laboratories in Q1 2017 and has held it in 4 quarters since.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.